'Breakthrough' Blueprint: US FDA Draft Guideline Outlines Revised Expedited Development Program

The Breakthrough Devices Program is the established Expedited Access Pathway with some statutory updates, including the addition of 510(k)-pathway devices. But FDA also uses the congressionally-mandated draft guidelines to outline some new features in the program that are not in the statute, including a process for "breakthrough device sprint discussions."

Light bulb in a blue print

[Editors' note: For details on all devices for which companies have publicly disclosed designation for the Breakthrough/EAP program, check out Medtech Insight's US Expedited Access Tracker.]

US FDA introduced the concept of "sprint" discussions in a draft guidance posted Oct. 24 on the Breakthrough...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation